VVOS - What's Going On With Vivos Therapeutics Stock? | Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million shares of common stock by selling shareholders.
The Details:
Vivos said that if the warrants held by the selling stockholder are exercised in full for cash, the company would receive approximately $8.4 million.
The company announced receipt of all required regulatory approvals to enable Medicare reimbursement for its CARE oral medical devices on Tuesday.
Vivos reported its fourth-quarter financial results at the end of March. The company reported quarterly losses of $3.05 per share which missed the analyst consensus estimate of $1.91 by 59.69% and quarterly sales of $3.248 million which also missed the analyst estimate.
Related ...